Patmoz
Murang’a-based medic and entrepreneur Dr. Moses Mwangi has welcomed the government’s announcement of a strategic shift in Kenya’s polio immunization programme from the Oral Polio Vaccine (OPV) to the Inactivated Polio Vaccine (IPV), administered through injection.
The Ministry of Health confirmed that the nationwide transition is part of Kenya’s broader effort to align with World Health Organization (WHO) recommendations and strengthen long-term protection against the poliovirus.
Dr. Mwangi described the move as a “long overdue milestone” in the country’s public health journey, noting that the injectable vaccine provides stronger and more reliable immunity.
“This transition marks a new chapter in our fight against polio. It enhances protection for our children and reflects Kenya’s commitment to modern, evidence-based immunization strategies,” he said.
The IPV, unlike the oral version, contains an inactivated form of the virus, eliminating the rare risk of vaccine-derived infections associated with OPV. Health experts say the shift will significantly boost Kenya’s capacity to eradicate polio and protect future generations from the debilitating disease.
Dr. Mwangi praised the Ministry for prioritizing child health and reaffirmed his support for initiatives that promote universal immunization coverage across the country.
Shadrack Nyakoe
